Simulations Plus, Inc. logo SLP - Simulations Plus, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $18.50 DETAILS
HIGH: $18.50
LOW: $18.50
MEDIAN: $18.50
CONSENSUS: $18.50
UPSIDE: 0.38%

Stock News

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

SAN DIEGO, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for investors who suffered losses and whether they may recover those losses under federal securities laws. On April 3, 2025, Simulations Plus reported its financial results for the second quarter of fiscal 2025 and maintained full-year revenue guidance of $90 million to $93 million.

Aug 20, 2026 06:28 AM globenewswire.com (Hide legal announcements)
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

SAN DIEGO, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for investors who suffered losses and whether they may recover those losses under federal securities laws. On April 3, 2025, Simulations Plus reported its financial results for the second quarter of fiscal 2025 and maintained full-year revenue guidance of $90 million to $93 million.

Aug 20, 2026 06:28 AM globenewswire.com (Hide legal announcements)
Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris

Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the Company's previously announced acquisition by Altaris, LLC. The expiration of the HSR waiting period satisfies one of the regulatory cond.

Aug 13, 2026 01:00 PM businesswire.com
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP

Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Simulations Plus, Inc. (NasdaqGS: SLP) to affiliates of Altaris, LLC. Under the terms of the proposed transaction, shareholders of Simulations will receive $18.50 in cash for each share of Simulations that they own. KSF is seeking to determine whether this consideration and the process that led to i.

Jul 30, 2026 08:05 AM businesswire.com (Hide legal announcements)
Simulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws

Simulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws

San Diego, California--(Newsfile Corp. - July 29, 2026) - Robbins LLP announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated securities laws or breached fiduciary duties owed to shareholders The investigation concerns whether Simulation Plus made materially false or misleading statements or omitted material information regarding its financial reporting, internal controls, and business outlook. Investors who purchased Simulation Plus securities and suffered losses may have legal rights.

Jul 29, 2026 01:25 PM newsfilecorp.com
SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO, July 28, 2026 /PRNewswire/ -- Robbins LLP announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated securities laws or breached fiduciary duties owed to shareholders. The investigation concerns whether Simulation Plus made materially false or misleading statements or omitted material information regarding its financial reporting, internal controls, and business outlook.

Jul 28, 2026 06:00 PM prnewswire.com (Hide legal announcements)
Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation

Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation

SAN DIEGO--(BUSINESS WIRE)---- $SLP #SimulationPlus--Robbins LLP announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated securities laws or breached fiduciary duties owed to shareholdersThe investigation concerns whether Simulation Plus made materially false or misleading statements or omitted material information regarding its financial reporting, internal controls, and business outlook.Investors who purchased Simulation Plus securities and suf.

Jul 27, 2026 04:06 PM businesswire.com

Price Targets